Dr. Charles Robert Young, MD

Dr. Young practices at Facey Medical Group - Valencia Specialty & Women's Center in Valencia, California.

Dr. Young's NPI, 1528236965, was assigned on February 20, 2008. Dr. Young graduated from David Geffen School of Medicine at UCLA in 2003. Dr. Young holds California license A89031.

Dr. Young's primary practice is Facey Medical Group - Valencia Specialty & Women's Center, at 23803 McBean Parkway, Valencia, CA 91355. The practice phone is (818) 869-7034.

Dr. Young's primary practice is Facey Medical Group - Valencia Specialty & Women's Center in Valencia, California. Dr. Young is also affiliated with Henry Mayo Newhall Hospital. The medical group on file is Facey Medical Group. Dmand AI also links Dr. Young to 2 more hospitals, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Young practices, 7 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Young's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Young is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Young's licenses on file in 2 states: California and Ohio.

Dmand AI lists arm, wrist, hand fracture and dislocation, arthritis, bursitis, fluid in a joint, hip replacement, joint arthropathy, joint or bone infection and joint pain among the conditions Dr. Young treats.

CMS data shows 1,355 Medicare services from Dr. Young across 14 procedure codes in 2024, for 245 Medicare patients. Medicare paid $91,846 for them.

CMS counts 245 Medicare patients who saw Dr. Young in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have arthritis, and 75% have high blood pressure. 23% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Young's median patient age at 68, with 59% women.

In 2024, Dr. Young wrote 1,144 Medicare Part D claims for 323 patients. 98% of them were for generic drugs. CMS names the drug for 1,072 of them, across 21 drugs with 11 or more claims each, at $16,181 in total drug cost. In 2023, CMS named 772 claims across 15 drugs.

Dr. Young accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 15 procedures of lower limb (leg) arthroscopy (minimally invasive joint repair) by Dr. Young, more than 88% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 27 general payments to Dr. Young from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. Zimmer Biomet Holdings, Inc. paid the most, $778.

Dmand AI lists 1 award for Dr. Young, most recently CMS Stage 1 2012 in 2012.

Dr. Young graduated from David Geffen School of Medicine at UCLA in 2003.

Dr. Young is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.